Compare FLL & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLL | COCH |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9M | 52.5M |
| IPO Year | 2014 | 2021 |
| Metric | FLL | COCH |
|---|---|---|
| Price | $1.11 | $0.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $3.00 | $2.17 |
| AVG Volume (30 Days) | ★ 241.1K | 66.9K |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.45 | ★ 17.45 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $302,376,000.00 | $241,000.00 |
| Revenue This Year | $3.39 | N/A |
| Revenue Next Year | $5.36 | $17.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 3.53 | ★ 7.11 |
| 52 Week Low | $1.01 | $0.36 |
| 52 Week High | $3.37 | $0.95 |
| Indicator | FLL | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 20.19 | 32.32 |
| Support Level | N/A | $0.36 |
| Resistance Level | $2.74 | $0.74 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 10.07 | 0.00 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.